Andrew D. Ashe - Net Worth and Insider Trading
Andrew D. Ashe Net Worth
The estimated net worth of Andrew D. Ashe is at least $3 Million dollars as of 2024-11-29. Andrew D. Ashe is the See Remarks of Verve Therapeutics Inc and owns about 342,509 shares of Verve Therapeutics Inc (VERV) stock worth over $2 Million. Andrew D. Ashe is also the General Counsel & EVP of Dyax Corp and owns about 34,127 shares of Dyax Corp (DYAX) stock worth over $1 Million. Details can be seen in Andrew D. Ashe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew D. Ashe has not made any transactions after 2024-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew D. Ashe
Andrew D. Ashe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew D. Ashe owns 3 companies in total, including Applied Genetic Technologies Corp (AGTC) , Dyax Corp (DYAX) , and Verve Therapeutics Inc (VERV) .
Click here to see the complete history of Andrew D. Ashe’s form 4 insider trades.
Insider Ownership Summary of Andrew D. Ashe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGTC | Applied Genetic Technologies Corp | 2017-08-01 | General Counsel |
| DYAX | Dyax Corp | 2016-01-22 | General Counsel & EVP |
| VERV | Verve Therapeutics Inc | 2024-05-14 | See Remarks |
Andrew D. Ashe Latest Holdings Summary
Andrew D. Ashe currently owns a total of 2 stocks. Among these stocks, Andrew D. Ashe owns 342,509 shares of Verve Therapeutics Inc (VERV) as of May 14, 2024, with a value of $2 Million and a weighting of 60.16%. Andrew D. Ashe also owns 34,127 shares of Dyax Corp (DYAX) as of August 3, 2015, with a value of $1 Million and a weighting of 39.84%.
Latest Holdings of Andrew D. Ashe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2024-05-14 | 342,509 | 5.78 | 1,979,702 |
| DYAX | Dyax Corp | 2015-08-03 | 34,127 | 38.41 | 1,310,818 |
Holding Weightings of Andrew D. Ashe
Andrew D. Ashe Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew D. Ashe has made a total of 2 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Verve Therapeutics Inc is the acquisition of 76,000 shares on May 14, 2024, which cost Andrew D. Ashe around $475,760.
According to the SEC Form 4 filings, Andrew D. Ashe has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 62,320 shares on August 3, 2015, which brought Andrew D. Ashe around $2 Million.
Insider Trading History of Andrew D. Ashe
- 1
Andrew D. Ashe Trading Performance
GuruFocus tracks the stock performance after each of Andrew D. Ashe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D. Ashe is -17.36%. GuruFocus also compares Andrew D. Ashe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D. Ashe within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew D. Ashe's insider trading performs compared to the benchmark.
Performance of Andrew D. Ashe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.54 | | | | | |
| Relative Return to S&P 500(%) | -4.36 | | | | | |
Andrew D. Ashe Ownership Network
Andrew D. Ashe Owned Company Details
What does Applied Genetic Technologies Corp do?
Who are the key executives at Applied Genetic Technologies Corp?
Andrew D. Ashe is the General Counsel of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .
Applied Genetic Technologies Corp (AGTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Genetic Technologies Corp Insider Transactions
Andrew D. Ashe Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew D. Ashe. You might contact Andrew D. Ashe via mailing address: C/o Dyax Corp., 55 Network Drive, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
